
JAMA, Journal Year: 2025, Volume and Issue: unknown
Published: March 24, 2025
This study evaluates the amount of out-of-pocket cost savings Medicare Part D beneficiaries would have experienced if a proposed $2 drug list model had been in place 2021.
Language: Английский